Pinetree Therapeutics, based in Cambridge, United States, announced on October 29 that it has recently completed a Series B ...
Pinetree Therapeutics, a preclinical-stage biotechnology company pioneering targeted protein degraders for drug-resistant cancers, announced the successful closing of an oversubscribed $47 million ...
GLP-1 drugs were initially developed for type 2 diabetes but are now widely used to treat obesity. Novo Nordisk and Eli Lilly lead in GLP-1 drug production, with others like Viking Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback